TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Proportion of participants with favorable outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Diabetes Self-Management Scale (DSMS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: AUC(0-tlast) of ASA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of ASA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of treatment-emergent adverse events as assessed by CTCAE v5.0
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with abnormal and clinically significant safety laboratory tests
Endpoint domain: Adverse events/effects
Primary endpoint: Child social communication
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Local reactions (redness, swelling, and pain at the injection site)
Endpoint domain: Adverse events/effects
Primary endpoint: Systemic events (fever, fatigue, headache, vomiting, nausea, diarrhea, muscle pain, and joint pain)
Endpoint domain: Adverse events/effects
Primary endpoint: Newly diagnosed chronic medical conditions (NDCMC)
Endpoint domain: Adverse events/effects
Primary endpoint: RSV A serum neutralizing titers (NTs)_GMT
Endpoint domain: Physiological/clinical
Primary endpoint: RSV B serum neutralizing titers (NTs)_GMT
Endpoint domain: Physiological/clinical
Primary endpoint: Diagnostic rate of whole genome sequencing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic rate of brain reactive autoantibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in minutes per week of moderate-to-vigorous intensity aerobic physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: central anterior chamber depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discharge location
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Generic sense of ability to adapt
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Movement speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smoothness of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of ShA9 Survival
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative urinary and fecal recovery of total radioactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of unchanged form and its major metabolites in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment Preference for CIDP Therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CIDP Signs, Symptoms, and Impacts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving MBL Volume < 80 mL and ≥ 50% Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICG-Signal in the intestinal tract
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement in upper extremity motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of post-procedure pancreatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Feasibility of recruitment overall
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Presence of Toxoplasma gondii IgG Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Classified as afflicted by Toxoplasma gondii using response times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Homework Performance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Work accuracy
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Work pace
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Occurrence of Treatment emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of device failures
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in self-reported quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Star Excursion Balance test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in Mean Sensor Glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Simulated taekwondo Combat (actions/time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Asthma Exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change of baseline body image ideals
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of body appreciation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of sociocultural attitudes towards appearance
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change of self-compassion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Minnesota Dexterity Test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dual-task effect on performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility and Acceptability of MAYA
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Sessions completed over study time period
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in NRS abdominal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Bristol stool scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Activation of the peroneal muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Fetal RhD status determination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Telerehabilitation Usability Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pharmacokinetic similarity for metabolite 21A-Gly-human insulin (M1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants reporting local reactogenicity signs and symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants reporting systemic reactogenicity signs and symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Engagement in Meaningful Activities Scale
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: ADHD-RS total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adipose tissue dependent take rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immediate effect of surgical hand antisepsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect assessed 3-hours after surgical hand antisepsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ultrasound pattern in respiratory tract infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Efficacy of hyaluronic acid injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Recording diagnostic 3D-image
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Applying rubberdam isolation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Selective cutting from image
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Irritable Bowel Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: course success
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: permanent learning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: critical thinking skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of Sexual Assault
Endpoint domain: Adverse events/effects
Primary endpoint: Number of ED Visits caused by Assault Injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Number of human trafficking cases
Endpoint domain: Adverse events/effects
Primary endpoint: number of days alive without mechanical ventilation
Endpoint domain: Mortality/survival
Primary endpoint: Vertical bone dimensional changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in blood pressure between arms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: average pain severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cognitive ability assessment (WAIS-V)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive flexibility (Trail Making Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Working memory (NIH Toolbox List Sorting Working Memory Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Decision-making competence (Adult Decision-Making Competence test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Psychological wellbeing (Psychological Wellbeing Scale)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sleep quality (Pittsburgh Sleep Quality Index)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Study Engagement Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mobile Application Rating Scale User Version (uMARS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Gremlin-1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Syndecan-4 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IL-1 Beta levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily Opioid Use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total opioid usage over two weeks
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Event-related Brain Potential: Reward Positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Paired Associative Learning test (CANTAB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Spatial Working Memory test (CANTAB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Food Insecurity and Access
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Fiber Intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Microbial Richness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in total scores of nasal symptomatology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically meaningful increases in Moderate to Vigorous Physical Activity (MVPA)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to Nursing Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Generate Alert
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention (App) Utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Maximum concentration (Cmax) of seladelpar and metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach Cmax (Tmax) of seladelpar and metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration curve versus time curve of seladelpar and metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time-to-treatment-failure
Endpoint domain: Mortality/survival
Primary endpoint: Suicide related behaviors
Endpoint domain: Mortality/survival
Primary endpoint: Waveform Morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conduction Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eyelid closure achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of CMV- and VZV-specific T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Phenotype of CMV- and VZV-specific T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Function of CMV- and VZV-specific T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Upper extremity motor performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative acute kidney injury (PO-AKI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: cardiovascular complication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: neurological complication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Serum IgG concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Bilateral upper limb volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICG lymphography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of morbid progression events
Endpoint domain: Mortality/survival
Primary endpoint: IC composite score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensory capacity assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Resting Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neutralizing antibody level for HPV types
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of clinical dicotomic indexes for gingivitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Finger Tapping
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 9-Hole Pegboard Dexterity Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unified Parkinson Disease Rating Scale (UPDRS) Section 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: occurrence and frequency of Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: occurrence of Dose Limiting Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in oral temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in respiratory rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Net Adverse Cardiac Events (NACE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Elasticity of Abdominal Wall Muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of infection complications
Endpoint domain: Adverse events/effects
Primary endpoint: GV oocyte maturation rate at 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of MII oocytes between the two groups at 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Malassezia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Time to symptoms relief onset of acute HAE attack
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Treatment Emergent Adverse Events and Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of responders with seroconversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: left ventricular assist device (LVAD) insertion
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients prescribed a second dose of inclisiran
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Median time between first and second prescribed doses
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of re-operation
Endpoint domain: Adverse events/effects
Primary endpoint: Baseline proportion and location of different immune cell subsets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Baseline tumor gene alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Baseline clinical characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PK parameters of active metabolite ZX-7101
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: O2 Saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: baby's crying duration
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total radioactivity recovery rates in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total radioactivity recovery rates in feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cumulative total radioactivity recovery rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overall CEUS/CT Concordance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact on treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound-associated pain measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of darkness or redness of the skin surrounding the wounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Measurement of wound size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in WHO Clinical Progression scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of electrocardiographic changes and/or rhythm disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PAAINESD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ASA classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Modified Japanese Orthopaedic Association (mJOA) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: The five Times Sit to Stand Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The muscle quality index (MQI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Geriatric Depression Scale (GDS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: The 6 minutes' walk test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short form Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Saliva levels of acetaldehyde
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with a signal to noise ratio > 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hypotension after induction of general anaesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-center analytical variability of thrombin generation measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: proportion of death
Endpoint domain: Mortality/survival
Primary endpoint: recurrent or refractory angina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: average power performance of Romanian deadlifts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: concentric peak power performance of Romanian deadlifts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: eccentric peak power performance of Romanian deadlifts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PYY
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: intensity of residual neuropathic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neural functioning during moral decision-making
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Safety and tolerability of C5252
Endpoint domain: Adverse events/effects